Blog Posts

Top 5 Fuld + Company Insights From 2018

Posted January 8, 2019| Fuld + Company

This past year was one that was met with advancements, changes, and unanticipated shifts across a variety of industries. Fuld + Company produced thoughtful research and analysis addressing the causes and origins of these shifts, providing competitive intelligence and facilitating strategic plans to help clients navigate a highly disruptive environment.

As we embark on 2019, we’ve generated a list of our most popular posts from 2018 that touch on many of the issues that kept business leaders on their toes:

5. Top Business Challenges for Competing in the CPG + Retail 

Learn more about the top four challenges the Consumer Products + Retail Industry faces in a continuously shifting landscape

4. A Winning Competitive Strategy Needs More than Market Research

Learn why it’s critical for companies to leverage existing data to manage uncertain futures

3. Competing in the Financial Services Sector: The Industry’s Top Business Challenges

Learn how financial services firms can seize opportunities in times of disruption

2. The Undeniable Rise of Challenger Banks in the United Kingdom: What Should the Big Four Do?

Learn how banking dynamics shifted in the United Kingdom when new entrants appealed to younger, tech-savvy consumers

1. What is Competitive Intelligence?

 Learn why it’s important to leverage competitive intelligence to gain advantages in the marketplace and set robust strategies

This year, we’ll continue to monitor and evaluate the disruptive forces changing the way businesses compete in and service the market. We are committed to regularly providing our analysis and outlook pertaining to our areas of expertise and keep our readers apprised of changes ahead.

Tags: , ,

Related Resources

Read More

Questions CPGs Should Ask to Make Sense of a Confused Organic/GMO-Free Marketplace

As Organic Week in Washington D.C. kicks off, Fuld + Company Examines Issues Regarding the Future of Food Labeling   […]

Read More

Faces of Fuld: Q+A with CEO, Diane Borska

Diane Borska, CEO and President, maintains a deep history working with Fuld + Company and has held a variety of […]

Read More

Analysis Of The Trastuzumab Biosimilar Market As Herceptin Exclusivity Nears An End

To expand on the Fuld + Company, Pharma Companies to Watch Report, Analyst Robert Browne drilled in on the Biosimilar Marketplace in […]

Subscribe to our mailing list for our latest updates: